TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 or the 'J' compound) with activity against drug-sensitive and drug-resistant TB. TMC207 inhibits the proton pump of ...

Currently, several states have outbreaks. In Kansas City, where cases have increased 148%, two deaths have been reported ...

Anti-tuberculosis drug-induced acute kidney injury is not rare in an aging population. It usually develops within two months of treatment and resolves within three months after onset. Although ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

About 40% of the health workers who collected data in the country’s HIV hotspots either lost their jobs in February or will ...

Fresenius Kabi, an operating company of Fresenius, and Formycon AG, announced today that the U.S. Food and Drug Administration (FDA) designated Otulfi® (ustekinumab-aauz) as an interchangeable ...

Study highlights rising obesity rates among Indian women, urging urgent public health action to address fertility and ...

It's been two decades since the denialism war was won in South Africa. Now HIV scientists and government are pitted against each other once again, with one side saying the health minister is in denial ...

While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

At the Sapien Center, those dabbling in the Make America Healthy Again movement can find connection, community, and ...

It's been two decades since the denialism war was won in South Africa. Now HIV scientists and government are pitted against each other once again, with one side saying the health minister is in denial ...